Immucor, Inc. Strategic SWOT Analysis Review [Report Updated: 25042018] Prices from USD $125 04:07
Immucor, Inc. Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.
This uptotheminute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
Business description A detailed description of the company's operations and business divisions.
Corporate strategy GlobalData's summarization of the company's business strategy.
SWOT analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history Progression of key events associated with the company.
Major products and services A list of major products, services and brands of the company.
Key competitors A list of key competitors to the company.
Key employees A list of the key executives of the company.
Executive biographies A brief summary of the executives' employment history.
Key operational heads A list of personnel heading key departments/functions.
Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.
Key manufacturing facilities A list of key manufacturing facilities of the company.
Highlights
Immucor, Inc. Immucor is an invitro diagnostics company, which specializes in the area of pretransfusion diagnostics. It carries out the development, production and sale of a comprehensive line of reagents and automated systems. The company's products are used in performing the tests to detect and identify certain properties of the cell and serum components of human blood before the process of blood transfusion. Its major customers include hospitals, clinical laboratories and blood banks. Immucor offers its solutions to blood banks, transfusion laboratories and small and mediumsized hospitals. The company has operations in Germany, Italy, Portugal, Canada, Spain, Belgium, France, India, Japan, the UK and the US; and it has manufacturing facilities in US and Canada. Immucor is headquartered in Norcross, Georgia, the US.
Immucor, Inc. Key Recent Developments
Jan 16,2018: Avi Pelossof Appointed President and CEO of Immucor
Jul 26,2017: Immucor and Mohawk Medbuy Corporation Sign 10 Year Automation Agreement for CoLabs
Feb 17,2017: Immucor Announces the Launch of Pak Lx RUO in the United States
Reasons to Buy
Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.
Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company